1,2,4-triazolyl-3-alanine
- $90 - $4310
- Product name: 1,2,4-triazolyl-3-alanine
- CAS: 10109-05-4
- MF: C5H8N4O2
- MW: 156.14
- EINECS:233-301-2
- MDL Number:MFCD00055957
- Synonyms:1,2,4-triazolyl-3-alanine ;NSC76227;triazolealanine;(±)-2-Amino-3-(1,2,4-triazol-3-yl)propionic acid, DL-1,2,4-Triazole-3-alanine;1,2,4-Triazole-3-alanine;2-Amino-3-(4H-1,2,4-triazole-3-yl)propionic acid;H-(1,2,4-Triazol-3-yl)-D,L-alanine;α-Amino-1H-1,2,4-triazole-3-propionic acid
4 prices
Selected condition:
Brand
- Sigma-Aldrich
- TRC
Package
- 5mg
- 25mg
- 100mg
- 250mg
- ManufacturerSigma-Aldrich
- Product numberT9299
- Product descriptionβ-(1,2,4-Triazol-3-yl)-DL-alanine
- Packaging25mg
- Price$665
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberT9299
- Product descriptionβ-(1,2,4-Triazol-3-yl)-DL-alanine
- Packaging100mg
- Price$1960
- Updated2023-06-20
- Buy
- ManufacturerSigma-Aldrich
- Product numberT9299
- Product descriptionβ-(1,2,4-Triazol-3-yl)-DL-alanine
- Packaging250mg
- Price$4310
- Updated2024-03-01
- Buy
- ManufacturerTRC
- Product numberT767655
- Product description1,2,4-Triazolyl-3-alanine
- Packaging5mg
- Price$90
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich | T9299 | β-(1,2,4-Triazol-3-yl)-DL-alanine | 25mg | $665 | 2024-03-01 | Buy |
Sigma-Aldrich | T9299 | β-(1,2,4-Triazol-3-yl)-DL-alanine | 100mg | $1960 | 2023-06-20 | Buy |
Sigma-Aldrich | T9299 | β-(1,2,4-Triazol-3-yl)-DL-alanine | 250mg | $4310 | 2024-03-01 | Buy |
TRC | T767655 | 1,2,4-Triazolyl-3-alanine | 5mg | $90 | 2021-12-16 | Buy |
Properties
Boiling point :454.1±55.0 °C(Predicted)
Density :1.527±0.06 g/cm3(Predicted)
storage temp. :−20°C
pka :1.81±0.10(Predicted)
Density :1.527±0.06 g/cm3(Predicted)
storage temp. :−20°C
pka :1.81±0.10(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|